BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

INC Research, Inc. CEO & COO Participate in Partnerships in Clinical Trials 2013


4/23/2013 9:15:45 AM

Raleigh, N.C., Apr. 22, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced CEO Jamie Macdonald and COO Alistair Macdonald will participate in key panel discussions at this year's Partnerships in Clinical Trials conference, April 21-24, 2013, in Orlando, Florida. Together with Vice President, Strategic Alliances Andrew Townshend, they will participate in four educational sessions covering a range of topics, including managing risk in outsourced clinical trials, translating data into meaningful insights and capturing metrics in a partnership.

"The Partnerships conference is a perfect forum for coming together and exchanging ideas with other industry leaders," said INC Research CEO Jamie Macdonald. "As a leader in clinical innovation, we look forward to sharing some of the forward-thinking strategies and tools we've been employing to drive overall improvements in efficiency and quality in the drug development process. Through innovation, our metrics-driven Trusted Process® and our extensive therapeutic expertise, we're helping biopharms make better use of their drug development capital."

INC Research Speaker Lineup at Partnerships:

• Executive Leadership Boardroom - CEO Jamie Macdonald will participate in a Quick-Fire Q&A session along with other invited CRO leaders as part of this inaugural event on Monday, April 22,at 3:15 p.m. Attendees of this invitation-only event will have an opportunity to connect and exchange ideas on designing the clinical trial landscape of the future with C-level executives from the top CROs.

• Jamie Macdonald also will participate in the "Managing Risk in Outsourced Clinical Trials through Risk Assessment, Risk Sharing and Risk-based Management Approaches," panel discussion taking place Tuesday, April 23, from 1:30-2:15 p.m.

• COO Alistair Macdonald will participate in a panel on "Translating Data into Meaningful Insights: Optimizing the Interface Among Key Stakeholders," also taking place Tuesday, April 23, from 1:30-2:15 p.m.

• Andrew Townshend, Vice President of Strategic Alliances, will present "Capturing Metrics in a Partnership: Does Fortune Favor the Brave?" on Wednesday, April 24, from 11:30 a.m.-12:10 p.m.

As a leading CRO providing a full range of Phase I to IV clinical development services on a worldwide scale, INC Research helps biopharms efficiently bring new drugs to market through a proven methodology that ensures consistent quality, reduced trial variability and complete transparency for every phase of a development program. Using advanced data monitoring and management systems, INC Research is able to provide a real-time status on all projects and test sites and help identify issues before they occur, giving sponsors a high level of visibility and predictability throughout their clinical trial programs.

For more information or to schedule a meeting at Partnerships in Clinical Trials, visit the INC Research site or stop by Booth #219 at the conference.

About INC Research

INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES